Long-term outcomes of resection for locoregional recurrence of colon cancer: A retrospective descriptive cohort study

Eur J Surg Oncol. 2021 Sep;47(9):2390-2397. doi: 10.1016/j.ejso.2021.05.003. Epub 2021 May 19.

Abstract

Introduction: Resection for isolated distant recurrence of colon cancer is well accepted. Resection for locoregionally recurrent colon cancer (LRCC) is not well studied. We evaluated the long-term outcomes of curative-intent resection for LRCC.

Methods: All patients undergoing curative-intent resection for LRCC at three specialized cancer centers affiliated with the University of Toronto were identified (1993-2017). Follow-up included serial clinical assessment, colonoscopy, CEA, and cross-sectional imaging. Overall survival (OS), cancer-specific survival (CSS) and time to re-recurrence were estimated using Kaplan-Meier method and cumulative incidence function. The association between resection margins and outcome was assessed with Cox models.

Results: 117 patients were included in the study cohort. Median follow-up was 53 months (IQR: 34-101). OS was 75% (95% CI: 68-84) at 5 years, and 69% (95% CI: 59-79) at 10 years. CSS was 78% (95% CI: 70-86) at 5 years and 72% (95% CI: 63-83) at 10 years. The rate of re-recurrence was 22% (95% CI: 14-31) at 5 years, and 27% (95% CI: 16-39) at 10 years. Negative resection margin (R0) was associated with improved OS (HR 3.33, 95% CI: 1.85-6.00, p < 0.01). There were no postoperative deaths; complications with Clavien-Dindo grade > II occurred in 12% of patients. Perioperative chemotherapy was used in 63% of patients and radiotherapy in 37%.

Conclusion: In selected patients with LRCC, excellent OS, CSS and low re-recurrence rates were observed, and R0 resection predicted better outcomes. These findings support consideration of resection for LRCC in fit patients after review at a multidisciplinary cancer conference.

Keywords: Colon cancer; Locally recurrent; Locoregional recurrence; Recurrence; Resection.

MeSH terms

  • Adenocarcinoma / surgery*
  • Adenocarcinoma / therapy
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / surgery*
  • Colonic Neoplasms / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Margins of Excision
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / surgery*
  • Neoplasm Recurrence, Local / therapy
  • Neoplasm, Residual
  • Postoperative Complications / etiology
  • Proportional Hazards Models
  • Radiotherapy
  • Retrospective Studies
  • Survival Rate
  • Time Factors

Substances

  • Antineoplastic Agents